Clinical Trial Update: IT-TT as an Effective and Well-Tolerated Strategy for CNS Prop in High-Risk DLBCL: a Prospective Ph II Study [Phase 2]

View source ↗

Summary

A Phase 2 prospective trial from Zhejiang Cancer Hospital reports that intrathecal TT (IT-TT) appears to be an effective and well-tolerated strategy for CNS pro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Diffuse Large B-Cell Lymphoma (DLBCL), Intrathecal Chemotherapy | Phase 2 | Status: COMPLETED